Los Angeles Capital Management LLC Sana Biotechnology, Inc. Transaction History

Los Angeles Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$4.2 - $11.27 $270,450 - $725,709	-64,393 Reduced 47.83%	70,245 $702,000
Q4 2023 Feb 06, 2024	SELL	$2.8 - $4.55 $2,920 - $4,745	-1,043 Reduced 0.77%	134,638 $549,000
Q3 2023 Nov 06, 2023	BUY	$3.77 - $6.23 $3,932 - $6,497	1,043 Added 0.77%	135,681 $525,000
Q2 2023 Aug 03, 2023	SELL	$3.22 - $7.53 $11,914 - $27,861	-3,700 Reduced 2.67%	134,638 $802,000
Q1 2023 May 04, 2023	SELL	$3.11 - $4.92 $9,270 - $14,666	-2,981 Reduced 2.11%	138,338 $452,000
Q3 2022 Nov 02, 2022	SELL	$5.58 - $9.04 $90,228 - $146,176	-16,170 Reduced 10.27%	141,319 $848,000
Q2 2022 Aug 05, 2022	SELL	$4.12 - $9.35 $606,369 - $1.38 Million	-147,177 Reduced 48.31%	157,489 $1.01 Million
Q1 2022 May 06, 2022	BUY	$5.24 - $15.58 $1.6 Million - $4.75 Million	304,666 New	304,666 $2.52 Million

172

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $613M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.